Physician profile
Dunk A Ellis
NPI 1043342322
$1,211.96
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $376 · 2021: $146 · 2022: $65.26 · 2023: $39.16 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $304.99 | 2020-2024 | Farxiga |
| Lilly USA, LLC | $153.94 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.60 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $101.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $94.71 | 2019 | |
| Pfizer INC. | $79.64 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.08 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $71.34 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $37.24 | 2022-2023 | Spravato |
| Collegium Pharmaceutical, INC. | $28.55 | 2019 | |
| Orexo US, INC. | $23.63 | 2019-2020 | |
| Renalytix Ai, INC. | $19.06 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Allergan, INC. | $17.02 | 2019 | |
| Daiichi Sankyo INC. | $16.21 | 2019 | |
| Novo Nordisk INC | $15.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $15.00 | 2019 | |
| Astellas Pharma US INC | $13.77 | 2024 | Veozah |
| Abbvie INC. | $12.38 | 2021 | |
| Sentynl Therapeutics, INC. | $10.94 | 2019 | |
| Kaleo, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dunk Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.